OBJECTIVE： To provide reference for improving the national assessment programs of sampling and testing policy. METHODS： Questionnaire was designed to investigate the drug manufacturers’ attitude and suggestions to the national assessment programs of sampling and testing policy； SPSS 18.0 software was adopted to analyze the data； a reliability analysis was conducted for the 17 variables in the table； and a principal component analysis was conducted for the topics with strong correlation. RESULTS： A total of 340 questionnaires were sent out，314 were effectively received with the effective rate of 92％. the total internal consistency reliability coefficient Alpha was 0.92； the awareness coefficient of enterprise on the evaluation of sampling and testing was 9.78； 4.24 enterprises were relatively agree the evaluation of sampling and testing； the attitude coefficient of enterprise on the improvement of evaluation of sampling and testing was 13.39； and the average score of enterprise on the overall satisfaction scoring was 8.73. CONCLUSIONS： The drug enterprises show high overall recognition for the national assessment programs of sampling and testing policy， and willing to cooperate with the development， and hoping the policy can be improved.